Real-World Treatment Patterns and Outcomes with Oral Azacitidine Maintenance Therapy in Patients with Acute Myeloid Leukemia

被引：0
|
作者：
Krishnamurthy, Pramila [1 ]
Houghton, Katherine [2 ]
Lorenz, Nicola [3 ]
Williams, Paula [4 ]
Currie, Lisa [4 ]
Vigil, Carlos E. [5 ]
Ziba, Nomthandazo [2 ]
Bello, Fareedat [2 ]
Sieluk, Jan [5 ]
Strocchia, Maria [5 ]
Li, Yeran [5 ]
Kapp-Schwoerer, Silke [6 ,7 ]
机构：
[1] Kings Coll Hosp London, London, England
[2] RTI Hlth Solut, Manchester, England
[3] Bristol Myers Squibb, Munich, Germany
[4] Bristol Myers Squibb, Uxbridge, England
[5] Bristol Myers Squibb, Princeton, NJ USA
[6] Klinikum Stadt Ludwigshafen, Med Klin A, Ludwigshafen, Germany
[7] Zentrum Haematol Neoplasien, Klinikum Stadt Ludwigshafen, Ludwigshafen, Germany
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-198362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2426 / 2426
页数：1
相关论文
共 50 条
  • [21] Treatment patterns, duration and outcomes of pemetrexed maintenance therapy in patients with advanced NSCLC in a real-world setting
    Winfree, Katherine B.
    Torres, Aracelis Z.
    Zhu, Yajun Emily
    Muehlenbein, Catherine
    Aggarwal, Himani
    Woods, Susan
    Abernethy, Amy
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 817 - 827
  • [22] Oral Azacitidine Maintenance Therapy in Acute Myeloid Leukemia after Frontline Hypomethylating Agent and Venetoclax
    Canavan, Cody
    Knight, Thomas G.
    Shah, Nilay A.
    Chojecki, Aleksander L.
    Ai, Jing
    Levine, Jonathan K.
    Osei-Boateng, Kwabena
    Hiremath, Adarsh
    Grunwald, Michael R.
    BLOOD, 2024, 144 : 6036 - 6037
  • [23] Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey
    Medeiros, Bruno C.
    Pandya, Bhavik J.
    Hadfield, Anna
    Pike, James
    Wilson, Samuel
    Mueller, Cynthia
    Bui, Cat N.
    Flanders, Scott C.
    Rider, Alex
    Walsh, L. Elise Horvath
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 927 - 935
  • [24] Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy
    Acker, Fabian
    Chromik, Joerg
    Tiedjen, Emily
    Wolf, Sebastian
    Vischedyk, Jonas B.
    Makowka, Philipp
    Enssle, Julius C.
    Kouidri, Khouloud
    Sebastian, Martin
    Steffen, Bjoern
    Oellerich, Thomas
    Serve, Hubert
    Neubauer, Andreas
    Schaefer, Jonas A.
    Bittenbring, Joerg T.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (05) : 623 - 630
  • [25] Real-World Treatment Patterns and Comparative Effectiveness Among a Population of Elderly Patients with Acute Myeloid Leukemia (AML)
    Medeiros, Bruno C.
    Satram-Hoang, Sacha
    Momin, Faiyaz
    Parisi, Monika
    BLOOD, 2018, 132
  • [26] Real-World Treatment Patterns and Outcomes Among Patients with Hairy Cell Leukemia
    Karve, Sudeep
    Divino, Victoria
    Gaughan, Andrew
    DeKoven, Mitch
    Gao, Guozhi
    Lanasa, Mark
    BLOOD, 2015, 126 (23)
  • [27] A real-world evaluation of treatment (Tx) patterns and outcomes of acute myeloid leukemia (AML) induction therapies in the community setting
    Maher, Keri Renee
    Brown-Bickerstaff, Cherrishe
    Qiu, Ying
    McBride, Ali
    Liassou, Djibril
    Laney, JaLyna
    Garretson, Marne
    Huggar, David
    Gajra, Ajeet
    Chen, Jiafan
    Hughes, David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia
    He, Fiona
    Sapkota, Smarika
    Parker, Sarah
    Defor, Todd
    Warlick, Erica
    Ustun, Celalettin
    Eckfeldt, Craig
    Rashidi, Armin
    Kurtzweil, Andy
    Weisdorf, Daniel
    Bejanyan, Nelli
    LEUKEMIA & LYMPHOMA, 2018, 59 (10) : 2352 - 2359
  • [29] Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia
    Matthews, Andrew H.
    Perl, Alexander E.
    Luger, Selina M.
    Loren, Alison W.
    Gill, Saar I.
    Porter, David L.
    Babushok, Daria V.
    Maillard, Ivan P.
    Carroll, Martin P.
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Stadtmauer, Edward A.
    Paralkar, Vikram R.
    Bruno, Ximena Jordan
    Hwang, Wei -Ting
    Margolis, David
    Pratz, Keith W.
    BLOOD ADVANCES, 2022, 6 (13) : 3997 - 4005
  • [30] Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia
    Zhu, Jinbing
    Wu, Qiuji
    Wang, Jinjin
    Niu, Ting
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (04) : 375 - 382
12345